ELIZABETH POHL: Open Payments
NPI 1033883723 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 33 payments from 17 companies in 2025. Trend: 2023 $1,369 · 2024 $1,130 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| Merck Sharp & Dohme LLC | 3 | $94 |
| Ipsen Biopharmaceuticals, Inc | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| Eisai Inc. | 3 | $77 |
| BeOne Medicines USA, Inc. | 2 | $58 |
| Incyte Corporation | 2 | $46 |
| ABBVIE INC. | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Caris MPI, Inc. | 1 | $33 |
Products named: Onivyde, BRUKINSA, Lenvima, KISQALI, FRUZAQLA, KEYTRUDA, MI CANCER SEEK, KEYTRUDA QLEX.
Industry payments across MI — which companies pay providers there.
